Logo

Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Share this
Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Shots:

  • Valeo has started commercial shipment of Redesca and Redesca HP- its low molecular weight heparin ("LMWH") biosimilar across Canada
  • The LMWH is being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism and is now increasingly used as a 1L of defense tool in the fight against COVID-19
  • Redesca is a low molecular weight heparin biosimilar

  Ref: PRNewswire | Image: Valeo

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Related News/Articles

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions